LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 83

Suchoptionen

  1. Artikel ; Online: Russian SARS-CoV-2 vaccine.

    Caddy, Sarah

    BMJ (Clinical research ed.)

    2020  Band 370, Seite(n) m3270

    Mesh-Begriff(e) Betacoronavirus ; COVID-19 ; COVID-19 Vaccines ; Clinical Trials, Phase III as Topic ; Coronavirus Infections/prevention & control ; Evidence-Based Medicine ; Global Health ; Government Regulation ; Humans ; Pandemics/prevention & control ; Patient Safety ; Pneumonia, Viral/prevention & control ; Risk ; Russia ; SARS-CoV-2 ; Viral Vaccines
    Chemische Substanzen COVID-19 Vaccines ; Viral Vaccines
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-08-24
    Erscheinungsland England
    Dokumenttyp Editorial
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.m3270
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Developing a vaccine for covid-19.

    Caddy, Sarah

    BMJ (Clinical research ed.)

    2020  Band 369, Seite(n) m1790

    Mesh-Begriff(e) Betacoronavirus ; COVID-19 ; COVID-19 Vaccines ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Drug Design ; Drug Discovery ; Drug Repositioning ; Humans ; Pandemics/prevention & control ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus/drug effects ; Viral Vaccines
    Chemische Substanzen COVID-19 Vaccines ; Spike Glycoprotein, Coronavirus ; Viral Vaccines
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-05-04
    Erscheinungsland England
    Dokumenttyp Editorial
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.m1790
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Buch ; Online: Developing a vaccine for covid-19

    Caddy, Sarah

    2020  

    Schlagwörter EDITORIALS ; covid19
    Sprache Englisch
    Erscheinungsdatum 2020-05-04 07:55:29.0
    Verlag BMJ Publishing Group Ltd
    Erscheinungsland us
    Dokumenttyp Buch ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Developing a vaccine for covid-19

    Caddy, Sarah

    BMJ

    2020  , Seite(n) m1790

    Schlagwörter covid19
    Sprache Englisch
    Verlag BMJ
    Erscheinungsland uk
    Dokumenttyp Artikel ; Online
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.m1790
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  5. Buch ; Online: Russian SARS-CoV-2 vaccine

    Caddy, Sarah

    2020  

    Schlagwörter EDITORIALS ; covid19
    Sprache Englisch
    Erscheinungsdatum 2020-08-24 04:06:02.0
    Verlag BMJ Publishing Group Ltd
    Erscheinungsland us
    Dokumenttyp Buch ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Russian SARS-CoV-2 vaccine

    Caddy, Sarah

    BMJ

    2020  , Seite(n) m3270

    Schlagwörter covid19
    Sprache Englisch
    Verlag BMJ
    Erscheinungsland uk
    Dokumenttyp Artikel ; Online
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.m3270
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Virus neutralisation by intracellular antibodies.

    Bottermann, Maria / Caddy, Sarah L

    Seminars in cell & developmental biology

    2021  Band 126, Seite(n) 108–116

    Abstract: For decades antibodies were largely thought to provide protection in extracellular spaces alone, mediating their effector functions by mechanisms such as entry-blocking, complement activation and phagocyte recruitment. However, a wealth of research has ... ...

    Abstract For decades antibodies were largely thought to provide protection in extracellular spaces alone, mediating their effector functions by mechanisms such as entry-blocking, complement activation and phagocyte recruitment. However, a wealth of research has shown that antibodies are also capable of neutralising numerous viruses inside cells. Efficacy has now been demonstrated at virtually all intracellular stages of the viral life cycle. Antibodies can neutralise viruses in endosomes by blocking uncoating, fusion mechanisms, or new particle egress. Neutralisation can also occur in the cytosol via recruitment of the intracellular antibody receptor TRIM21. In addition to these direct neutralisation effects, recent research has shown that antibodies can mediate virus control indirectly by promoting MHC class I presentation and thereby increasing the CD8 T cell response. This provides valuable new insight into how non-neutralising antibodies can mediate potent protection in vivo. Overall, the importance of understanding the mechanisms of intracellular neutralisation by antibodies is highlighted by the ongoing need to develop new methods to control viruses. Using or inducing antibodies to block virus replication inside cells is now an innovative approach used by several vaccination and therapeutic strategies.
    Mesh-Begriff(e) Antibodies, Viral ; Complement Activation
    Chemische Substanzen Antibodies, Viral
    Sprache Englisch
    Erscheinungsdatum 2021-11-12
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 1312473-0
    ISSN 1096-3634 ; 1084-9521
    ISSN (online) 1096-3634
    ISSN 1084-9521
    DOI 10.1016/j.semcdb.2021.10.010
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Protective mechanisms of nonneutralizing antiviral antibodies.

    Chandler, Tawny L / Yang, Agnes / Otero, Claire E / Permar, Sallie R / Caddy, Sarah L

    PLoS pathogens

    2023  Band 19, Heft 10, Seite(n) e1011670

    Abstract: Antibodies that can bind to viruses but are unable to block infection in cell culture are known as "nonneutralizing antibodies." Such antibodies are nearly universally elicited following viral infection and have been characterized in viral infections ... ...

    Abstract Antibodies that can bind to viruses but are unable to block infection in cell culture are known as "nonneutralizing antibodies." Such antibodies are nearly universally elicited following viral infection and have been characterized in viral infections such as influenza, rotavirus, cytomegalovirus, HIV, and SARS-CoV-2. It has been widely assumed that these nonneutralizing antibodies do not function in a protective way in vivo and therefore are not desirable targets of antiviral interventions; however, increasing evidence now shows this not to be true. Several virus-specific nonneutralizing antibody responses have been correlated with protection in human studies and also shown to significantly reduce virus replication in animal models. The mechanisms by which many of these antibodies function is only now coming to light. While nonneutralizing antibodies cannot prevent viruses entering their host cell, nonneutralizing antibodies work in the extracellular space to recruit effector proteins or cells that can destroy the antibody-virus complex. Other nonneutralizing antibodies exert their effects inside cells, either by blocking the virus life cycle directly or by recruiting the intracellular Fc receptor TRIM21. In this review, we will discuss the multitude of ways in which nonneutralizing antibodies function against a range of viral infections.
    Mesh-Begriff(e) Animals ; Humans ; Antibodies, Viral ; Virus Diseases ; Influenza, Human ; Receptors, Fc ; Antiviral Agents ; Antibodies, Neutralizing ; HIV Antibodies
    Chemische Substanzen Antibodies, Viral ; Receptors, Fc ; Antiviral Agents ; Antibodies, Neutralizing ; HIV Antibodies
    Sprache Englisch
    Erscheinungsdatum 2023-10-05
    Erscheinungsland United States
    Dokumenttyp Review ; Journal Article
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7374
    ISSN (online) 1553-7374
    ISSN 1553-7374
    DOI 10.1371/journal.ppat.1011670
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang